LIU, Z.,
ZHANG, R.,
CHEN, X.,
YAO, P.,
YAN, T.,
LIU, W.,
YAO, J.,
ZHAO, S.,
SOKHATSKII, A.,
GAREEV, I. (2019) -molecule compounds with potential therapeutic
effects. Finally, we verified the expression levels of the hub genes
LV, L.,
ZHANG, L.,
LI, R.,
LI, Y.,
YANG, R.,
LI, C.,
FANG, R.,
SHABANOVA, A.,
LI, X.,
LIU, Y.,
LIANG, H.,
ZHOU, Y.,
SHAN, H.,
ZHENG, N. (2020) therapies and drugs have a good
effect on cardiac conduction delay. Metformin (Met) has a protective
effectBogliolo, M.,
Catucci, I.,
Caleca, L.,
Lasheras, S.V.,
Pujol, R.,
Kiiski, J.I.,
Muranen, T.A.,
Barnes, D.R.,
Dennis, J.,
Michailidou, K.,
Bolla, M.K.,
Leslie, G.,
Figlioli, G. (2019) , with greater
effects for the ER-negative and triple-negative breast cancer (TNBC) subtypes. We tested the three
Baltina, L.A.,
Hour, M.-J.,
Liu, Y.-C.,
Chang, Y.-S.,
Huang, S.-H.,
Lai, H.-C.,
Kondratenko, R.M.,
Petrova, S.F.,
Yunusov, M.S.,
Lin, C.-W. (2021) assays on the cytopathic
effect (CPE) and viral infectivity of ZIKV in three different human cell lines
Пути развития иммунотерапии колоректального рака low efficacy and the development of a number of side
effects with damage to the liver, lung
Galimova, E.F.,
Gromenko, I.D.,
Gilyazova, I.R.,
Gromenko, D.D.,
Galimov, K.Sh.,
Abdeeva, G.R.,
Gromenko, Yu.Yu.,
Khusnutdinova, E.K.,
Galimov, Sh.N. (2024) of the
effectiveness of ART programs on the level of expression of exosomal microRNAs. The experimental group included
, it is necessary to develop an
effective therapy for NF1. The
effectiveness of complex therapy of NF1 with use
with potential therapeutic
effects. Results: A total of 325 upregulated genes and 103 downregulated genes